Skip navigation
Skip navigation

Potential for methotrexate exposure through contamination during parenteral use as an immunosuppressan

Wong, L. S.; Tymms, Kathleen; Buckley, Nicholas


Background: To evaluate whether the risk of methotrexate (MTX) exposure through skin contamination using parenteral doses of 25 mg warrants special oncology handling precautions during administration. Methods: We conducted a study with six human volunteers deliberately exposed to an entire dose of 25 mg MTX solution on their skin for 30 min. Serum levels of MTX were measured at baseline, 2, 4, 8, 12 and 24 h as well as serum homocysteine at baseline and 24 h after clinical exposure....[Show more]

CollectionsANU Research Publications
Date published: 2009
Type: Journal article
Source: Internal Medicine Journal
DOI: 10.1111/j.1445-5994.2008.01716.x


File Description SizeFormat Image
01_Wong_Potential_for_methotrexate_2009.pdf786.83 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator